Mayo Clinic, a large-scale medical and research center, has entered joint ventures with two startups to develop and commercialize an AI-powered remote diagnostic and management platform that would support clinical decision-making, providing diagnostic insights and recommendations. 

The first joint venture, called Lucem Health, was formed together with Commure, a healthcare software company that helps develop interoperable healthcare applications. Mayo invested  USD 6 million in Series A funding to collate data from remote monitoring devices, develop algorithms, and create diagnostics tools. 

The second joint venture company, called Anumana, was formed in partnership with nference, a company that synthesizes biomedical knowledge into actionable insights, to develop algorithms for early disease detection and prediction. Anumana raised USD 25.7 million in Series A funding and is developing a neural network algorithm using ECG signals for early heart disease detection, with plans to obtain US Food & Drug Administration approval in 2021. 

Founded in 1889, the Minnesota-based Mayo Clinic is a non-profit healthcare provider focused on integrated health care, digital health, medical research, and educational programs.